Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

1.4%

2 terminated/withdrawn out of 147 trials

Success Rate

92.6%

+6.0% vs industry average

Late-Stage Pipeline

12%

17 trials in Phase 3/4

Results Transparency

0 of 25 completed trials have results

Key Signals

49 recruiting

Enrollment Performance

Analytics

N/A

68(58.1%)

Phase 2

18(15.4%)

Early Phase 1

13(11.1%)

Phase 4

9(7.7%)

Phase 3

8(6.8%)

Phase 1

1(0.9%)

117Total

N/A(68)

Phase 2(18)

Early Phase 1(13)

Phase 4(9)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (147)

Showing 20 of 147 trials

NCT07284225Not ApplicableCompleted

Effects of Single-Dose Nicotinamide Riboside (NR) on Sleep

Role: lead

NCT07814677Phase 2Not Yet Recruiting

Efficacy and Safety of Intracochlear Injection of Glucocorticoid Through the Round Window Membrane in Patients With Profound or Complete Sudden Sensorineural Hearing Loss

Role: lead

NCT06622044Not ApplicableRecruiting

Vision Therapy Versus Prism Treatment in Small-angle Acute Acquired Concomitant Esotropia

Role: lead

NCT06237790Recruiting

Auditory Restoration and Outcomes After Gene Therapy and Cochlear Implantation: a PRospective Cohort Analysis (AURORA)

Role: lead

NCT07778797Not ApplicableRecruiting

Guangke Lenses in Congenital Cataract

Role: lead

NCT07769515Not ApplicableNot Yet Recruiting

Efficacy of Internet-based Cognitive Behavioral Therapy for Insomnia in Patients With Tinnitus and Insomnia

Role: lead

NCT07749079Not Yet Recruiting

Risk Factors for Postoperative Nausea and Vomiting After Nasal Surgery Under General Anesthesia

Role: lead

NCT07522879Phase 2Recruiting

A Study of Becotatug Vedotin (MRG003) Combined With Epirubicin as Neoadjuvant Therapy for EGFR-Positive, Unresectable Recurrent Sinonasal Adenoid Cystic Carcinoma

Role: lead

NCT07614828Phase 2Withdrawn

Exploratory Clinical Study of Neoadjuvant Immunotherapy Combined With Chemotherapy in Malignant Melanoma of Nasal and Paranasal Mucosa

Role: lead

NCT07652489Recruiting

Surgery Plus Postoperative Radiotherapy for T4 Sinonasal Adenoid Cystic Carcinoma: A Prospective Observational Study

Role: lead

NCT05963542Not ApplicableCompleted

Efficacy of Online Acceptance and Commitment Therapy and Sound Therapy for Patients With Tinnitus and Insomnia

Role: lead

NCT07616141Phase 2Not Yet Recruiting

Neoadjuvant Anlotinib and Epirubicin for T4 Sinonasal Adenoid Cystic Carcinoma